Novocure (NASDAQ:NVCR)

A non-invasive, portable device that treats glioblastomas with low intensity, alternating electrical fields.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Novocure (NASDAQ:NVCR) plus 5589 other startups.

Start Free 7 Day Trial Now

Learn More About Novocure (NASDAQ:NVCR)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With